Navigation Links
Discovery of key malaria proteins could mean sticky end for parasite
Date:7/9/2008

Scientists funded by the Wellcome Trust have identified a key mechanism that enables malaria-infected red blood cells to stick to the walls of blood vessels and avoid being destroyed by the body's immune system. The research, published today in the journal Cell, highlights an important potential new target for anti-malarial drugs.

Malaria is one of the world's biggest killers, killing over a million people every year, mainly children and pregnant women in Africa and south east Asia. It is caused by the malaria parasite, which is injected into the bloodstream from the salivary glands of infected mosquitoes. There are a number of different species of parasite, but the deadliest is the Plasmodium falciparum parasite, which accounts for 90% of deaths from malaria.

The malaria parasite infects healthy red blood cells, where it reproduces, producing up to thirty-two new daughter parasites. The parasite secretes a "glue", known as PfEMP1, which travels to the surface of the infected red blood cells, leading to the formation of the knobs on the surface of the cells. The cells become sticky and adhere to the walls of the blood vessels. This prevents the cells being flushed through the spleen, where the parasites would be destroyed by the body's immune system, but also restricts blood supply to vital organs.

Now, an international collaboration of scientists has identified eight new proteins that transport the P. falciparum parasite's "glue" to the surface of the infected red blood cells. The researchers, led by Professor Alan Cowman from the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, have shown that removing just one of these proteins prevents the infected red blood cells from sticking to the walls of the blood vessels.

"These findings greatly enhance our understanding of how the malaria parasite commandeers the red blood cell for its own survival and avoids our immune defences," says Pr
'/>"/>

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
Source:Eurekalert

Page: 1 2

Related medicine news :

1. 9/11 Workers Refute Citys Allegation of Discovery Abuse and Malingering
2. Discovery of gene mechanism could bring about new ways to treat metastatic cancer
3. MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real-Life Medical Mysteries on Discovery Health
4. NIAID creates HIV vaccine discovery branch
5. Could new discovery about a shape-shifting protein lead to a mighty morpheein bacteria fighter?
6. Core Informatics Deploys Core LIMS to Support Antibody Discovery at Fabrus
7. Dynamin drug discovery team win prestigious international epilepsy grant
8. Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research
9. New Molecule Discovery Shows Promise Against Tamoxifen-Resistant Breast Cancers
10. Stem cell discovery sheds light on placenta development
11. Discovery of new signal pathway important to diabetes research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Attorney Joseph W. Belluck of Belluck...asbestos have been found in toys in past holiday s...RWEB) December 6, 2009 -- As parents shop for chil... be alert to reports of recalls due to lead paint ...l injury lawyer., , ,“Close to 230,000 child...
(Date:12/5/2009)CAPE TOWN, South Africa, December 5 The first Football,for Hope Centre in Khayelitsha in the outskirts of Cape Town opened its doors,today (5 December 2009). FIFA President Joseph S. Blatter was join
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
Breaking Medicine News(10 mins):Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3
...ON, May 18 Dr. Andree Bates, President of the Pha...ivering a MasterClass on how to tell if you are ma... Eularis, WHAT: MasterClass on the latest t... WHEN: 12 June 2009, WHERE: 1 Northumberlan...
...ston) - African-American women who were younger at..., were more likely to report a history of childhoo...researcher at Boston University,s Slone Epidemiolo...years). , The study, which appears currently on-l...
...d volume perfusion acquisition, intuitive post-pro...ngine for comprehensive workflow efficiency and pa...d leading cause of death in the United States, str...irst few hours are the defining time when a quick ...
...NING, Germany and FREMONT, Calif., May 18 SCM Mic...SMY), a leading provider of solutions that open th...500 mobile terminal is one of the first upgradeab...d in Germany. , , "With the certification of our...
...RCLIFF MANOR, N.Y., May 18 SETO Holdings, Inc. (P...itive agreement to acquire from Sanjay Srivastava ...ers, Inc. ("AHC"), a Maryland corporation formed i...f the AHC acquisition that the public company shal...
...al trials using new strategies show promise for be...y 18 (HealthDay News) -- Vaccines made up of virus...longer-lasting protection against flu viruses than...ce as quickly as conventional vaccines, according ...
Other Medicine News:Health News:MEDIA ALERT - Eularis to Hold Pharmaceutical Marketing ROI MasterClass in London 2Health News:Study finds higher prevalence of early menarche among survivors of childhood sexual abuse 2Health News:Siemens Demonstrates Groundbreaking Approach to Stroke Diagnosis at ASNR 2009 2Health News:Siemens Demonstrates Groundbreaking Approach to Stroke Diagnosis at ASNR 2009 3Health News:Siemens Demonstrates Groundbreaking Approach to Stroke Diagnosis at ASNR 2009 4Health News:SCM Microsystems' Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program 2Health News:SCM Microsystems' Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program 3Health News:SCM Microsystems' Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program 4Health News:SETO Holdings, Inc. Signs Agreement to Acquire Advanced Hearing Centers, Inc. and Will Dispose of All Existing Business; New Management to be Installed 2Health News:New Methods Could Speed Production of Flu Vaccines 2
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 49063 1AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 49063 2AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 49063 3Peripheral nerve repair with fat precursor cells led to wider nerves and less muscle atrophy 8857 1Peripheral nerve repair with fat precursor cells led to wider nerves and less muscle atrophy 8857 2Reportable Food Registry Draft Guidance Published for Comment by FDA 49058 1Reportable Food Registry Draft Guidance Published for Comment by FDA 49058 2
... Animal Use in Cosmetics and Chemicals Testing, A...d,that results of a recently completed US and Euro...on MatTek,s EpiDerm in vitro human skin tissue,equ...d sensitivity and,specificity for EpiDerm to be ac...g for determining human skin irritation by the Eur...
...am to evaluate TAXUS(R) Element(TM) Platinum Chrom..., Mass., Oct. 8 Boston Scientific,Corporation (NY...nrollment in,the PERSEUS trial, designed to evalua...(TM) paclitaxel-eluting coronary stent. The PERSEU...nts at 100 U.S. and,international centers since Ju...
Other Medicine Technology:MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4
Impulse II
Slimtine S
Fineline II Sterox Atrial J
VascoTip P 9/60 PU M
Medicine Products: